Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06430008
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-05-28
First Post:
2024-05-21
Brief Title:
The Relationship Between Total Sialic Acid and Superoxide Dismutase and the Diagnosis and Prognosis of Lipoid Pneumonia
Sponsor:
Hu Yinan
Organization:
China-Japan Friendship Hospital
Study Overview
Official Title:
A Study to Explore the Correlation Between Total Sialic Acid Combined With Superoxide Dismutase and the Diagnosis and Prognosis of Lipoid Pneumonia
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to explore the correlation between total sialic acid combined with superoxide dismutase and the diagnosis and prognosis of lipid pneumonia in the patient with lipid pneumonia cough bacterial and fungal pneumonia cryptogenic organizing pneumonia pulmonary alveolar proteinosis lung mucinous adenocarcinoma and pulmonary edema The main question it aims to answer is
Whether superoxide dismutase SOD and total sialic acid TSA could be used as diagnostic markers to distinguish lipid pneumonia from patient with cough and bacterial and fungal pneumonia cryptogenic organizing pneumonia pulmonary alveolar proteinosis lung mucinous adenocarcinoma and pulmonary edema whether SOD and TSA be associated with the prognosis of patients with lipid pneumonia
Participants will answer online survey questions about their symptoms changes in oxygen status and changes in the most recent CT image of the lung for up to 10 years after treatment We will count participants baseline data including gender age smoking history comorbidities lung function imaging findings hormone use or not ICU treatment death or not the type of cause of lipid pneumonia how it is diagnosed and their baseline SOD and TSA
Whether superoxide dismutase SOD and total sialic acid TSA could be used as diagnostic markers to distinguish lipid pneumonia from patient with cough and bacterial and fungal pneumonia cryptogenic organizing pneumonia pulmonary alveolar proteinosis lung mucinous adenocarcinoma and pulmonary edema whether SOD and TSA be associated with the prognosis of patients with lipid pneumonia
Participants will answer online survey questions about their symptoms changes in oxygen status and changes in the most recent CT image of the lung for up to 10 years after treatment We will count participants baseline data including gender age smoking history comorbidities lung function imaging findings hormone use or not ICU treatment death or not the type of cause of lipid pneumonia how it is diagnosed and their baseline SOD and TSA
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None